The Safety and Efficacy of Phage Therapy for Infections in Cardiac and Peripheral Vascular Surgery: A Systematic Review
Abstract
:1. Background
2. Methods
2.1. Search Strategy
2.2. Study Selection Criteria
2.3. Data Extraction and Critical Appraisal
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
BD | twice daily; |
CIED | cardiac implantable electronic device; |
CRP | C-reactive protein; |
CT | computed tomography; |
EVAR | endovascular aortic repair; |
LVAD | left ventricular assist device; |
MSSA | methicillin-susceptible Staphylococcus aureus; |
PET-CT | positron emission tomography-computed tomography; |
PFU | plaque forming unit; |
PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses; |
QID | four times daily; |
TDS | three times daily; |
TEVAR | thoracic endovascular aortic repair; |
WBC | white blood cell count. |
References
- Chakfé, N.; Diener, H.; Lejay, A.; Assadian, O.; Berard, X.; Caillon, J.; Fourneau, I.; Glaudemans, A.W.J.M.; Koncar, I.; Lindholt, J.; et al. Editor’s Choice—European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections. Eur. J. Vasc. Endovasc. Surg. 2020, 59, 339–384. [Google Scholar] [CrossRef] [PubMed]
- Wilson, W.R.; Bower, T.C.; Creager, M.A.; Amin-Hanjani, S.; O’Gara, P.T.; Lockhart, P.B.; Darouiche, R.O.; Ramlawi, B.; Derdeyn, C.P.; Bolger, A.F.; et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation 2016, 134, e412–e460. [Google Scholar] [CrossRef] [PubMed]
- Lumish, H.S.; Cagliostro, B.; Braghieri, L.; Bohn, B.; Mondellini, G.M.; Antler, K.; Feldman, V.; Kleet, A.; Murphy, J.; Tiburcio, M.; et al. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy. ASAIO J. 2022, 68, 1450–1458. [Google Scholar] [CrossRef] [PubMed]
- NHS Getting It Right First Time. Surgical Site Infection Survey 2019 Survey Results. Available online: https://gettingitrightfirsttime.co.uk/wp-content/uploads/2022/11/SSI-report-2019-results-review12.9.22-FINAL.pdf (accessed on 24 February 2023).
- Tello-Díaz, C.; Palau, M.; Muñoz, E.; Gomis, X.; Gavaldà, J.; Fernández-Hidalgo, N.; Bellmunt-Montoya, S. Methicillin-Susceptible Staphylococcus aureus Biofilm Formation on Vascular Grafts: An In Vitro Study. Microbiol. Spectr. 2023, 11, e0393122. [Google Scholar] [CrossRef] [PubMed]
- Frei, E.; Hodgkiss-Harlow, K.; Rossi, P.J.; Edmiston, C.E.; Bandyk, D.F. Microbial Pathogenesis of Bacterial Biofilms: A Causative Factor of Vascular Surgical Site Infection. Vasc. Endovasc. Surg. 2011, 45, 688–696. [Google Scholar] [CrossRef] [PubMed]
- Sharma, D.; Misba, L.; Khan, A.U. Antibiotics versus Biofilm: An Emerging Battleground in Microbial Communities. Antimicrob. Resist. Infect. Control 2019, 8, 76. [Google Scholar] [CrossRef]
- Argyriou, C.; Georgiadis, G.S.; Lazarides, M.K.; Georgakarakos, E.; Antoniou, G.A. Endograft Infection After Endovascular Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis. J. Endovasc. Ther. 2017, 24, 688–697. [Google Scholar] [CrossRef]
- Chanishvili, N. Phage Therapy—History from Twort and d’Herelle Through Soviet Experience to Current Approaches. In Advances in Virus Research; Elsevier: Amsterdam, The Netherlands, 2012; Volume 83, pp. 3–40. ISBN 978-0-12-394438-2. [Google Scholar]
- Uyttebroek, S.; Chen, B.; Onsea, J.; Ruythooren, F.; Debaveye, Y.; Devolder, D.; Spriet, I.; Depypere, M.; Wagemans, J.; Lavigne, R.; et al. Safety and Efficacy of Phage Therapy in Difficult-to-Treat Infections: A Systematic Review. Lancet Infect. Dis. 2022, 22, e208–e220. [Google Scholar] [CrossRef]
- Suh, G.A.; Lodise, T.P.; Tamma, P.D.; Knisely, J.M.; Alexander, J.; Aslam, S.; Barton, K.D.; Bizzell, E.; Totten, K.M.C.; Campbell, J.L.; et al. Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob. Agents Chemother. 2022, 66, e0207121. [Google Scholar] [CrossRef]
- Scottish Health Technologies Group. H.I.S. SHTG Recommendation. Available online: https://shtg.scot/our-advice/bacteriophage-therapy-for-patients-with-difficult-to-treat-bacterial-infections/ (accessed on 24 February 2023).
- Stacey, H.J.; De Soir, S.; Jones, J.D. The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials. Antibiotics 2022, 11, 1340. [Google Scholar] [CrossRef]
- Wright, A.; Hawkins, C.H.; Anggard, E.E.; Harper, D.R. A Controlled Clinical Trial of a Therapeutic Bacteriophage Preparation in Chronic Otitis Due to Antibiotic-Resistant Pseudomonas aeruginosa; a Preliminary Report of Efficacy. Clin. Otolaryngol. 2009, 34, 349–357. [Google Scholar] [CrossRef] [PubMed]
- Ooi, M.L.; Drilling, A.J.; Morales, S.; Fong, S.; Moraitis, S.; Macias-Valle, L.; Vreugde, S.; Psaltis, A.J.; Wormald, P.-J. Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus. JAMA Otolaryngol.-Head Neck Surg. 2019, 145, 723–729. [Google Scholar] [CrossRef] [PubMed]
- Slopek, S.; Weber-Dabrowska, B.; Dabrowski, M.; Kucharewicz-Krukowska, A. Results of Bacteriophage Treatment of Supparative Bacterial Infections in the Years 1981–1986. Arch. Immunol. Ther. Exp. 1987, 35, 569–583. [Google Scholar]
- Maddocks, S.; Fabijan, A.P.; Ho, J.; Lin, R.C.Y.; Ben Zakour, N.L.; Dugan, C.; Kliman, I.; Branston, S.; Morales, S.; Iredell, J.R. Bacteriophage Therapy of Ventilator-Associated Pneumonia and Empyema Caused by Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 2019, 200, 1179–1181. [Google Scholar] [CrossRef] [PubMed]
- Rojas, S.V.; Junghans, S.; Fox, H.; Lazouski, K.; Schramm, R.; Morshuis, M.; Gummert, J.F.; Gross, J. Bacteriophage-Enriched Galenic for Intrapericardial Ventricular Assist Device Infection. Antibiotics 2022, 11, 602. [Google Scholar] [CrossRef]
- Grambow, E.; Junghans, S.; Kröger, J.C.; Reisinger, E.C.; Krause, B.J.; Groß, J. Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application. EJVES Vasc. Forum 2022, 56, 20–23. [Google Scholar] [CrossRef]
- Racenis, K.; Lacis, J.; Rezevska, D.; Mukane, L.; Vilde, A.; Putnins, I.; Djebara, S.; Merabishvili, M.; Pirnay, J.-P.; Kalnina, M.; et al. Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant Pseudomonas aeruginosa Left Ventricular Assist Device Driveline Infection. Viruses 2023, 15, 1210. [Google Scholar] [CrossRef]
- Püschel, A.; Skusa, R.; Bollensdorf, A.; Gross, J. Local Treatment of Driveline Infection with Bacteriophages. Antibiotics 2022, 11, 1310. [Google Scholar] [CrossRef]
- Green, S.I.; Clark, J.R.; Santos, H.H.; Weesner, K.E.; Salazar, K.C.; Aslam, S.; Campbell, J.W.; Doernberg, S.B.; Blodget, E.; Morris, M.I.; et al. A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clin. Infect. Dis. 2023, 77, ciad335. [Google Scholar] [CrossRef]
- Onallah, H.; Hazan, R.; Nir-Paz, R.; Israeli Phage Therapy Center (IPTC) Study Team. Compassionate Use of Bacteriophages for Failed Persistent Infections During the First 5 Years of the Israeli Phage Therapy Center. Open Forum Infect. Dis. 2023, 10, ofad221. [Google Scholar] [CrossRef]
- Blasco, L.; López-Hernández, I.; Rodríguez-Fernández, M.; Pérez-Florido, J.; Casimiro-Soriguer, C.S.; Djebara, S.; Merabishvili, M.; Pirnay, J.-P.; Rodríguez-Baño, J.; Tomás, M.; et al. Case Report: Analysis of Phage Therapy Failure in a Patient with a Pseudomonas aeruginosa Prosthetic Vascular Graft Infection. Front. Med. 2023, 10, 1199657. [Google Scholar] [CrossRef]
- Stroup, D.F.; Berlin, J.A.; Morton, S.C.; Olkin, I.; Williamson, G.D.; Rennie, D.; Moher, D.; Becker, B.J.; Sipe, T.A.; Thacker, S.B.; et al. Meta-Analysis of Observational Studies in Epidemiology: A Proposal for Reporting. JAMA 2000, 283, 2008–2012. [Google Scholar] [CrossRef]
- The Joanna Briggs Institute Critical Appraisal Tools—JBI. Available online: http://joannabriggs.org/research/critical-appraisal-tools.html (accessed on 31 March 2020).
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, S.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
- GraphPad Analyze A 2 × 2 Contingency Table. Available online: https://www.graphpad.com/quickcalcs/contingency1.cfm (accessed on 19 October 2023).
- Exarchos, V.; Tkhilaishvili, T.; Potapov, E.; Starck, C.; Trampuz, A.; Schoenrath, F. Successful Bacteriophage Treatment of Infection Involving Cardiac Implantable Electronic Device and Aortic Graft: A Trojan Horse Concept. Europace 2020, 22, 597. [Google Scholar] [CrossRef] [PubMed]
- Mulzer, J.; Trampuz, A.; Potapov, E.V. Treatment of Chronic Left Ventricular Assist Device Infection with Local Application of Bacteriophages. Eur. J. Cardiothorac. Surg. 2020, 57, 1003–1004. [Google Scholar] [CrossRef] [PubMed]
- Tkhilaishvili, T.; Merabishvili, M.; Pirnay, J.-P.; Starck, C.; Potapov, E.; Falk, V.; Schoenrath, F. Successful Case of Adjunctive Intravenous Bacteriophage Therapy to Treat Left Ventricular Assist Device Infection. J. Infect. 2021, 83, e1–e3. [Google Scholar] [CrossRef] [PubMed]
- Aslam, S.; Pretorius, V.; Lehman, S.M.; Morales, S.; Schooley, R.T. Novel Bacteriophage Therapy for Treatment of Left Ventricular Assist Device Infection. J. Heart Lung Transplant. 2019, 38, 475–476. [Google Scholar] [CrossRef]
- Aslam, S.; Lampley, E.; Wooten, D.; Karris, M.; Benson, C.; Strathdee, S.; Schooley, R.T. Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infect. Dis. 2020, 7, ofaa389. [Google Scholar] [CrossRef] [PubMed]
- Chan, B.K.; Turner, P.E.; Kim, S.; Mojibian, H.R.; Elefteriades, J.A.; Narayan, D. Phage Treatment of an Aortic Graft Infected with Pseudomonas aeruginosa. Evol. Med. Public Health 2018, 2018, 60–66. [Google Scholar] [CrossRef] [PubMed]
- Duplessis, C.; Biswas, B.; Hanisch, B.; Perkins, M.; Henry, M.; Quinones, J.; Wolfe, D.; Estrella, L.; Hamilton, T. Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy. J. Pediatr. Infect. Dis. Soc. 2018, 7, 253–256. [Google Scholar] [CrossRef]
- Petrovic Fabijan, A.; Lin, R.C.Y.; Ho, J.; Maddocks, S.; Ben Zakour, N.L.; Iredell, J.R.; Khalid, A.; Venturini, C.; Chard, R.; Morales, S.; et al. Safety of Bacteriophage Therapy in Severe Staphylococcus aureus Infection. Nat. Microbiol. 2020, 5, 465–472. [Google Scholar] [CrossRef] [PubMed]
- Rubalskii, E.; Ruemke, S.; Salmoukas, C.; Boyle, E.C.; Warnecke, G.; Tudorache, I.; Shrestha, M.; Schmitto, J.D.; Martens, A.; Rojas, S.V.; et al. Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery. Antibiotics 2020, 9, 232. [Google Scholar] [CrossRef] [PubMed]
- Tkhilaishvili, T.; Potapov, E.; Starck, C.; Mulzer, J.; Falk, V.; Trampuz, A.; Schoenrath, F. Bacteriophage Therapy as a Treatment Option for Complex Cardiovascular Implant Infection: The German Heart Center Berlin Experience. J. Heart Lung Transplant. 2022, 41, 551–555. [Google Scholar] [CrossRef] [PubMed]
- Slopek, S.; Durlakowa, I.; Weber-Dabrowska, B.; Kucharewicz-Krukowska, A.; Dabrowski, M.; Bisikiewicz, R. Results of Bacteriophage Treatment of Suppurative Bacterial Infections. I. General Evaluation of the Results. Arch. Immunol. Ther. Exp. 1983, 31, 267–291. [Google Scholar]
- Onsea, J.; Soentjens, P.; Djebara, S.; Merabishvili, M.; Depypere, M.; Spriet, I.; De Munter, P.; Debaveye, Y.; Nijs, S.; Vanderschot, P.; et al. Bacteriophage Application for Difficult-to-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol. Viruses 2019, 11, 891. [Google Scholar] [CrossRef] [PubMed]
- Little, J.S.; Dedrick, R.M.; Freeman, K.G.; Cristinziano, M.; Smith, B.E.; Benson, C.A.; Jhaveri, T.A.; Baden, L.R.; Solomon, D.A.; Hatfull, G.F. Bacteriophage Treatment of Disseminated Cutaneous Mycobacterium Chelonae Infection. Nat. Commun. 2022, 13, 2313. [Google Scholar] [CrossRef] [PubMed]
- Lusiak-Szelachowska, M.; Zaczek, M.; Weber-Dabrowska, B.; Miedzybrodzki, R.; Klak, M.; Fortuna, W.; Letkiewicz, S.; Rogoz, P.; Szufnarowski, K.; Jonczyk-Matysiak, E.; et al. Phage Neutralization by Sera of Patients Receiving Phage Therapy. Viral Immunol. 2014, 27, 295–304. [Google Scholar] [CrossRef]
- Gao, D.; Ji, H.; Wang, L.; Li, X.; Hu, D.; Zhao, J.; Wang, S.; Tao, P.; Li, X.; Qian, P. Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella Enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence. Microbiol. Spectr. 2022, 10, e0291422. [Google Scholar] [CrossRef]
- Glonti, T.; Pirnay, J.-P. In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success. Viruses 2022, 14, 1490. [Google Scholar] [CrossRef]
- Doub, J.B.; Wilson, E. Observed Transaminitis with a Unique Bacteriophage Therapy Protocol to Treat Recalcitrant Staphylococcal Biofilm Infections. Infection 2022, 50, 281–283. [Google Scholar] [CrossRef]
- Khatami, A.; Lin, R.C.Y.; Petrovic-Fabijan, A.; Alkalay-Oren, S.; Almuzam, S.; Britton, P.N.; Brownstein, M.J.; Dao, Q.; Fackler, J.; Hazan, R.; et al. Bacterial Lysis, Autophagy and Innate Immune Responses during Adjunctive Phage Therapy in a Child. EMBO Mol. Med. 2021, 13, e13936. [Google Scholar] [CrossRef] [PubMed]
- Grimont, P.A.; Grimont, F.; Lacut, J.Y.; Issanchou, A.M.; Aubertin, J. Treatment of a case of endocarditis caused by Serratia with bacteriophages. Nouv. Presse Med. 1978, 7, 2251. [Google Scholar] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Simpson, E.A.; MacLeod, C.S.; Stacey, H.J.; Nagy, J.; Jones, J.D. The Safety and Efficacy of Phage Therapy for Infections in Cardiac and Peripheral Vascular Surgery: A Systematic Review. Antibiotics 2023, 12, 1684. https://doi.org/10.3390/antibiotics12121684
Simpson EA, MacLeod CS, Stacey HJ, Nagy J, Jones JD. The Safety and Efficacy of Phage Therapy for Infections in Cardiac and Peripheral Vascular Surgery: A Systematic Review. Antibiotics. 2023; 12(12):1684. https://doi.org/10.3390/antibiotics12121684
Chicago/Turabian StyleSimpson, Emily A., Caitlin S. MacLeod, Helen J. Stacey, John Nagy, and Joshua D. Jones. 2023. "The Safety and Efficacy of Phage Therapy for Infections in Cardiac and Peripheral Vascular Surgery: A Systematic Review" Antibiotics 12, no. 12: 1684. https://doi.org/10.3390/antibiotics12121684